Drug profile · INN
paliperidone
BYANNLI (PREVIOUSLY PALIPERIDONE JANSSEN-CILAG INTERNATIONAL)
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
paliperidone (BYANNLI (PREVIOUSLY PALIPERIDONE JANSSEN-CILAG INTERNATIONAL)) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →Frequently asked questions
What is paliperidone?
paliperidone (BYANNLI (PREVIOUSLY PALIPERIDONE JANSSEN-CILAG INTERNATIONAL)) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for paliperidone?
BYANNLI (PREVIOUSLY PALIPERIDONE JANSSEN-CILAG INTERNATIONAL) is a marketed brand name for paliperidone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of paliperidone?
paliperidone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.